| Line item | 2025-09-30 FY | 2024-09-30 FY | 2023-09-30 FY | 2022-09-30 FY | 2021-09-30 FY |
|---|---|---|---|---|---|
| Revenue | – | – | $12.05B | $12.54B | $10.50B |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $11.10B | $10.09B | $10.36B | $10.13B | $7.66B |
| R&D | – | – | – | – | – |
| SG&A | – | – | – | – | – |
| Operating Income | $2.57B | $2.23B | $1.69B | $2.41B | $2.85B |
| Interest Expense | – | – | – | – | – |
| Tax Expense | – | – | – | – | – |
| Net Income | $1.36B | $1.14B | $500.00M | $1.11B | $1.51B |
| EPS (basic) | – | – | – | – | – |
| EPS (diluted) | – | – | – | – | – |
| Shares (diluted) | – | – | – | – | – |